February 19th 2020
Sarah Crafton, MD, discusses the personalized choice of undergoing secondary cytoreduction for patients with ovarian cancer.
December 21st 2019
Sarah Crafton, MD, discusses the impact of PARP inhibitors on patients with recurrent ovarian cancer.
December 4th 2019
Sarah Crafton, MD, gynecologic oncologist, Allegheny Health Network, discusses secondary surgical cytoreduction in recurrent ovarian cancer.